Sstyles, Pfizer could drive Vascepa's success on so many levels: 1. Superior marketing/existing army of sales reps around the world. 2. Influence with the FDA. (Maybe quash fish oil dietary supplements.) 3. Could promote the use of Vascepa to treat inflammation from C-19 and the vaccines. 4. Could provide support or structure a deal to co-promote/market Vascepa with Eddingpharm in China. 5. Pfizer is riding a wave of goodwill from its C-19 vaccine. If Pfizer began promoting Vascepa with a "worldwide campaign to tackle CVD, the greatest killer on the planet," people would listen...Pfizer could promote it as another way they are saving lives around the world. They could pull that off. Amarin in GIA mode? Not so much.